Prabhani Atukorale to Neoplasms
This is a "connection" page, showing publications Prabhani Atukorale has written about Neoplasms.
Connection Strength
1.031
-
Kane GI, Naylor TE, Lusi EF, Brassil ML, Wigglesworth K, Dinnell RW, Diaz-Infante MB, Whiteman LM, Lukas J, Winkler M, Josh R, Cerrutti J, Mori H, Gallucci S, Fitzgerald KA, Atukorale PU. Super-adjuvant nanoparticles for platform cancer vaccination. Cell Rep Med. 2025 Oct 21; 6(10):102415.
Score: 0.445
-
Atukorale PU, Moon TJ, Bokatch AR, Lusi CF, Routhier JT, Deng VJ, Karathanasis E. Dual agonist immunostimulatory nanoparticles combine with PD1 blockade for curative neoadjuvant immunotherapy of aggressive cancers. Nanoscale. 2022 Jan 27; 14(4):1144-1159.
Score: 0.344
-
Kane GI, Brassil ML, Diaz-Infante MB, Atukorale PU. Nanocarrier design for pathogen-inspired innate immune agonist delivery. Trends Immunol. 2024 09; 45(9):678-692.
Score: 0.103
-
Lorkowski ME, Atukorale PU, Ghaghada KB, Karathanasis E. Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy. Adv Healthc Mater. 2021 03; 10(5):e2001044.
Score: 0.079
-
Atukorale PU, Covarrubias G, Bauer L, Karathanasis E. Vascular targeting of nanoparticles for molecular imaging of diseased endothelium. Adv Drug Deliv Rev. 2017 04; 113:141-156.
Score: 0.059